baryawno lab

publications

picture-1

Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses

Authors:
Hirz T, Mei S, Sarkar H, Kfoury Y, Wu S, Verhoeven BM, Subtelny AO, Zlatev DV, Wszolek MW, Salari K, Murray E, Chen F, Macosko EZ, Wu CL, Scadden DT, Dahl DM, Baryawno N#, Saylor SJ#, Kharchenko PV#, Sykes DB#.

#Co-senior

Nature Communications
Year: 2023
Volume: 14
Issue: 663

cell_death__differentiation_cover

Role of reactive oxygen species in regulating 27-hydroxycholesterol-induced apoptosis of hematopoietic progenitor cells and myeloid cell lines

Authors:
Woo SY, Lee H, Park SM, Choi HS, Kim J, Kwon M, Sohn J, Nam JH, Kim HS, Song P, Baryawno N#, Kim YH#, Kim K#, Lee D#.

#Co-senior

Cell Death & Disease
Year: 2022
Volume: 3
Issue: 916

hero_image_-_stem_cell_collection-69d697eecd2a1afc600ed4c04f390959

A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma

Authors:
Alchahin AM*, Mei S*, Tsea I, Hirz T, Kfoury Y, Dahl D, Wu CL, Subtelny AO, Wu S, Scadden DT, Shin JH, Saylor PJ#,  Sykes DB#, Kharchenko PV#, Baryawno N#.

*Co-first
#Co-senior

Nature Communications
Year: 2022
Volume:
Issue:

jci

DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma

Authors:
Olsen TK*, Dyberg C*, Embaie BT, Alchahin A, Milosevic J, Ding J, Otte J, Tümmler C, Myrberg I, Westerhout EM, Koster J, Versteeg R, Ding HF, Kogner P,  Johnsen JI, Sykes DB#, Baryawno N#.

*Co-first
#Co-senior

Journal of Clinical Investigation Insights
Year: 2022
Volume: 7
Issue: 17

cover_crm

The immune cell atlas of human neuroblastoma

Authors:
Verhoeven BM*, Mei S*, Olsen TK, Gustafsson K, Valind A,  Lindström A, Gisselsson D, Fard SS, Hagerling C#, Kharchenko PV#, Kogner P#, Johnsen JI#, Baryawno N#.

*Co-first
#Co-senior

Cell Reports Medicine
Year: 2022
Volume: 3
Issue: 6

cover_cc

Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment

Authors:
Kfoury N*, Baryawno N* Severe N*, Mei S*, Gustafsson K*, Hirz T*, Brouse T, Scadden EW, Igolkina AA, Kokkaliaris K, Choi BD, Barkas N, Randolph MA, Shin JH, Saylor PJ, Scadden DT, Sykes DB, Kharchenko PV, and as part of the Boston Bone Metastases Consortium.

*Co-first

Cancer Cell
Year: 2021
Volume: 39
Page: 1439-1548

front-_page_sub1

A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia.

Authors:
Baryawno N*, Przybylski D*, Kowalczyk MS*, Kfoury Y, Severe N, Gustafsson UK, Kokkaliaris KD, Mercier F, Tabaka M, Hofree M, Dionne D, Papazian A, Lee D, Ashenberg O, Subramanian A, Vaishnav ED, Rozenblatt-Rosen O,  Regev A, Scadden DT.

*Co-first

Cell
Year: 2019
Volume: 177
Page: 1915-1932

baryawno-pub-3

Modulating Bone Marrow Hematopoietic Lineage Potential to Prevent Bone Metastasis in Breast Cancer.

Authors:
Ubellacker JM, Baryawno N, Severe N, DeCristo MJ, Sceneay J, Hutchinson JN, Haider MT, Rhee CS, Qin Y, Gregory WM, Garrido-Castro AC, Holen I, Brown JE, Coleman RE, Scadden DT, McAllister SS.

Cancer Research
Year: 2018
Volume: 78
Page: 5300-5314

baryawno-pub-2

dropEst: pipeline for accurate estimation of molecular counts in droplet-based single-cell RNA-seq experiments.

Authors:
Petukhov V, Guo J, Baryawno N, Severe N, Scadden DT, Samsonova MG, Kharchenko PV.

Genome Biology
Year: 2018
Volume: 19
Page: 78

baryawno-pub-4

Introduction to Single-Sell RNA Sequencing.

Authors:
Ohlsen TK, Baryawno N.

Current Protocols
Year: 2018
Volume: 122
Page: e57

128-1-cover

Bone marrow drives central nervous system regeneration after radiation injury.

Authors:
Dietrich J*, Baryawno N*, Nayyar N, Valtis YK, Yang B1, Ly I, Besnard A, Severe N, Gustafsson KU, Andronesi OC, Batchelor TT, Sahay A, Scadden DT.

*Co-first

Journal Of Clinical Investigation
Year: 2017
Volume: 128
Page: 281-293

cover.tif

Hematopoiesis: Reconciling Historic Controversies about the Niche.

Authors:
Baryawno N, Severe N, Scadden DT.

Cell Stem Cell
Year: 2017
Volume: 20
Page: 590-592

Graphical Abstract Sized

Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell.

Authors:
Hoggatt J, Singh P, Tate TA, Chou BK, Datari SR, Fukuda S, Liu L, Kharchenko PV, Schajnovitz A, Baryawno N, Mercier FE, Boyer J, Gardner J, Morrow DM, Scadden DT, Pelus LM.

Cell
Year: 2017
Volume: 172
Page: 191-204

f1.medium

Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils.

Authors:
Engblom C, Pfirschke C, Zilionis R, Da Silva Martins J, Bos SA, Courties G, Rickelt S, Severe N, Baryawno N, Faget J, Savova V, Zemmour D, Kline J, Siwicki M, Garris C, Pucci F, Liao HW, Lin YJ, Newton A, Yaghi OK, Iwamoto Y, Tricot B, Wojtkiewicz GR, Nahrendorf M, Cortez-Retamozo V, Meylan E, Hynes RO, Demay M, Klein A, Bredella MA, Scadden DT, Weissleder R, Pittet MJ.

Science
Year: 2017
Volume: 358
Issue: 6367

127-4-cover

Amino acid-insensitive mTORC1 regulation enables nutritional stress resilience in hematopoietic stem cells.

Authors:
Kalaitzidis D, Lee D, Efeyan A, Kfoury Y, Nayyar N, Sykes DB, Mercier FE, Papazian A, Baryawno N, Victora GD, Neuberg D, Sabatini DM, Scadden DT.

Journal of Clinical Investigation
Year: 2017
Volume: 127
Page: 1405-1413

cell-stem-cell-19-530-543-2016-n204c24468wlvt6phzgjm3vnlj7oi3c405inh61s1s

Proximity-Based Differential Single-Cell Analysis of the Niche to Identify Stem/Progenitor Cell Regulators.

Authors:
Silberstein L, Goncalves KA, Kharchenko PV, Turcotte R, Kfoury Y, Mercier F, Baryawno N, Severe N, Bachand J, Spencer JA, Papazian A, Lee D, Chitteti BR, Srour EF, Hoggatt J, Tate T, Lo Celso C, Ono N, Nutt S, Heino J, Sipilä K, Shioda T, Osawa M, Lin CP, Hu GF, Scadden DT.

Cell Stem Cell
Year: 2016
Volume: 19
Page: 530-543

cover.tif

Epigenetic Memory Underlies Cell Autonomous Heterogeneous Behavior of Hematopoietic Stem Cells

Authors:
Yu VWC , Yusuf RZ, OkiT, Wu J, Saez B, Wang X, Cook C, Baryawno N, Ziller MJ, Lee E, Gu H, Meissner A, Lin CP, Kharchenko PV, Scadden DT.

Cell 
Year: 2016
Volume: 167
Pages: 1310-1322

baryawno-lab-publication-cover-image-3

Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance

Authors:
Wickström M, Dyberg C, Milosevic J, Christer E, Calero R, Sveinbjörnsson B, Sandeé E, Darabi A, Siesjö P, Kool M, Kogner P, Baryawno N# & Johnsen J#.

#Co-senior

Nature Communications
Year: 2015
Volume: 25
Article Number: 8904

Baryawno Lab Publications

Frequent detection of human cytomegalovirus in neuroblastoma: A novel therapeutic target?

Authors:
Wolmer-Solberg N*, Baryawno N*, Rahbar A, Fuchs D, Odeberg J, Taher C, Wilhelmi V, Milosevic J, Mohammad AA, Martinsson T, Sveinbjörnsson B, Johnsen JI, Kogner P, Söderberg-Nauclér C.

International Journal of Cancer
Year: 2013
Volume: 133 (10)
Article Number:  2351-61

121-10-cover-source

Detection of human cytomegalovirus in medulloblastomas reveals a novel therapeutic target

Authors: 
Baryawno N, Rahbar A, Wolmer-Solberg N, Taher C, Odeberg J, Darabi A, Khan Z, Sveinbjörnsson B, Fuskevåg OM, Segerström L, Nordenskjöld M, Siesjö P, Kogner P, Johnsen JI and Söderberg-Nauclér C.

Journal of Clinical Investigation
Year: 2011
Volume: 121
Article Number: 4043-55

baryawno-lab-publication-cover-6

Small molecule inhibitors of PI3K/AKT signaling inhibit Wnt/β-catenin pathway crosstalk and suppress medulloblastoma growth.

Authors:
Baryawno N, Sveinbjörnsson B, Eksborg S, Chen CS, Kogner P, Johnsen JI.

Cancer Research
Year: 2011
Volume: 70
Pages: 266-76

baryawno-lab-publication-cover-7

Tumour growth promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets

Authors:
Baryawno N, Sveinbjörnsson B, Eksborg S, Orrego A, Segerström L, Öqvist CO, Holm S, Gustavsson B, Kågedal B, Kogner P, Johnsen JI.

Neuro-Oncology
Year: 2008
Volume: 10
Pages: 661-74